天津医科大学肿瘤医院Tianjin Medical University Cancer Institute & Hospital

该疾病的证据

依据官方公开数据来源筛选

1. Colorectal cancer

   Tianjin 天津市

   已发表研究

   • PAK2 mediates PhIP-induced proliferative and oxidative stress responses in colorectal cancer cells. Chemico-biological interactions, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology #5。

2. Breast cancer

   Tianjin 天津市

   已发表研究

   • Randomized phase 2 trial of a PARP inhibitor TSL-1502 in germline BRCA-mutated, HER2-negative locally advanced/metastatic breast cancer. Signal transduction and targeted therapy, 2026
   • ULBP1 is a prognostic biomarker associated with immune suppression in breast cancer. Frontiers in oncology, 2026

   另有 2 项已发表研究

   PubMed 收录了 4 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology #5。

3. Lung cancer

   Tianjin 天津市

   国家临床重点专科

   • Thoracic Surgery（B 级） https://www.tjmuch.com/yygk/yyjj/index_yg.shtml

   同时上榜：在复旦榜中为 Medical Oncology #5。

4. Liver cancer

   Tianjin 天津市

   已发表研究

   • Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology #5。

5. Cervical cancer

   Tianjin 天津市

   已发表研究

   • Comparative predictive performance of three machine learning algorithms for acute radiation enteritis risk among patients with cervical cancer undergoing radiotherapy: A prospective cohort study. Asia-Pacific journal of oncology nursing, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology #5。

6. Stomach cancer

   Tianjin 天津市

   已发表研究

   • Treatment-specific CT Radiomics Models To Predict Response To Neoadjuvant Therapy And Explore Individualized Treatment Selection In Gastric Cancer. Academic radiology, 2026
   • Neoadjuvant therapy reshapes the therapeutic value of distal lymphadenectomy in cT3/4a proximal gastric cancer. Science China. Life sciences, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology #5。

7. Prostate cancer

   Tianjin 天津市

   已发表研究

   • A prostate cancer-specific super-enhancer at 1q42.3 regulates the CAPN2 and KRT19. The Journal of biological chemistry, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology #5。

8. Thyroid cancer

   Tianjin 天津市

   已发表研究

   • Symptom Clusters and Quality of Life Among Patients with Thyroid Cancer During Early Survivorship: A National Multicenter Cross-Sectional Study. The oncologist, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology #5。

9. Nasopharyngeal carcinoma

   Tianjin 天津市

   已发表研究

   • Symptom-to-Diagnosis Interval, Treating-Center Context, and Survival in Nasopharyngeal Carcinoma in Nonendemic Northern China: A Multicenter Real-World Cohort Study. Head & neck, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology #5。

10. Esophageal cancer

    Tianjin 天津市

    国家临床重点专科

    • Thoracic Surgery（B 级） https://www.tjmuch.com/yygk/yyjj/index_yg.shtml

    已发表研究

    • Dynamic iterative coarse-to-fine prompt learning based on SAM for precise esophageal cancer gross target volume segmentation. Physics in medicine and biology, 2026

    PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

    同时上榜：在复旦榜中为 Medical Oncology #5。

11. Pancreatic cancer

    Tianjin 天津市

    复旦专科声誉排行榜 2023

    • Medical Oncology #5 https://www.fdygs.com/news2023-1.aspx

    国家临床重点专科

    • Medical Oncology（B 级） https://www.tjmuch.com/yygk/yyjj/index_yg.shtml

    研究平台

    • 国家恶性肿瘤临床医学研究中心 https://www.most.gov.cn/tztg/201306/t20130608_106459.html

12. Bone and soft tissue sarcoma

    Tianjin 天津市

    复旦专科声誉排行榜 2023

    • Medical Oncology #5 https://www.fdygs.com/news2023-1.aspx

    国家临床重点专科

    • Medical Oncology（B 级） https://www.tjmuch.com/yygk/yyjj/index_yg.shtml

    研究平台

    • 国家恶性肿瘤临床医学研究中心 https://www.most.gov.cn/tztg/201306/t20130608_106459.html